ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: As an example, this workflow was applied for determination of IC50 values for the anti-leukemia drug imatinib and other BCR-Abl tyrosine kinase inhibitors in the chronic myelogenous leukemia (CML) cell line K562.